13G Filing: D E Shaw and Ophthotech Corp. (OPHT)

Page 5 of 6 – SEC Filing

(c) Number of shares to which the person has:
(i) Sole power to vote or to direct the vote:
D. E. Shaw & Co., L.P.: -0- shares
David E. Shaw: -0- shares   
(ii) Shared power to vote or to direct the vote:
D. E. Shaw & Co., L.P.: 1,741,363 shares     
David E. Shaw: 1,741,363 shares   
(iii) Sole power to dispose or to direct the disposition
of:
D. E. Shaw & Co., L.P.: -0- shares   
David E. Shaw: -0- shares   
(iv) Shared power to dispose or to direct the disposition
of:
D. E. Shaw & Co., L.P.: 1,805,361 shares   
David E. Shaw: 1,805,361 shares   

David E. Shaw does not own any shares directly. By virtue of
David E. Shaw’s position as President and sole shareholder of D. E. Shaw & Co., Inc., which is the general partner of
D. E. Shaw & Co., L.P., which in turn is the manager and investment adviser of D. E. Shaw Valence Portfolios, L.L.C., the investment
adviser of D. E. Shaw Oculus Portfolios, L.L.C., and the managing member of (i) D. E. Shaw Investment Management, L.L.C., (ii)
D. E. Shaw Adviser, L.L.C., which in turn is the investment adviser of D. E. Shaw Asymptote Portfolios, L.L.C., and (iii) D. E.
Shaw Heliant Adviser, L.L.C., which in turn is the investment adviser of D. E. Shaw Heliant Capital, L.L.C., and by virtue of David
E. Shaw’s position as President and sole shareholder of D. E. Shaw & Co. II, Inc., which is the managing member of D. E. Shaw
& Co., L.L.C., which in turn is the manager of D. E. Shaw Oculus Portfolios, L.L.C. and the managing member of (i) D. E. Shaw
Manager, L.L.C., which in turn is the manager of D. E. Shaw Asymptote Portfolios, L.L.C., and (ii) D. E. Shaw Heliant Manager,
L.L.C., which in turn is the manager of D. E. Shaw Heliant Capital, L.L.C., David E. Shaw may be deemed to have the shared power
to vote or direct the vote of 1,741,363 shares, and the shared power to dispose or direct the disposition of 1,805,361 shares,
the 1,805,361 shares as described above constituting 5.0% of the outstanding shares and, therefore, David E. Shaw may be deemed
to be the beneficial owner of such shares. David E. Shaw disclaims beneficial ownership of such 1,805,361 shares.

Item 5. Ownership of Five Percent or Less of a Class

Not Applicable

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not Applicable

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

Not Applicable

Item 8. Identification and Classification of Members of the Group

Not Applicable

Item 9. Notice of Dissolution of Group

Not Applicable

Item 10. Certification

By signing below, each of D. E. Shaw & Co., L.P.
and David E. Shaw certify that, to the best of such reporting person’s knowledge and belief, the securities referred to above
were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of
the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purposes
or effect.

 

Follow Iveric Bio Inc. (NASDAQ:ISEE)